The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $94.39

Today's change-1.48 -1.54%
Updated March 28 4:01 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $94.39

Today's change-1.48 -1.54%
Updated March 28 4:01 PM EDT. Delayed by at least 15 minutes.

Sharp drop following new 20-day high

Edwards Lifesciences Corp closed sharply lower Tuesday, dropping (U.S.)$1.48 or 1.54% to (U.S.)$94.39 after setting a new 20-day high. Over the last five days, shares have gained 1.65%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 6.94% during the last year.

Key company metrics

  • Open(U.S.) $95.61
  • Previous close(U.S.) $95.87
  • High(U.S.) $96.49
  • Low(U.S.) $93.57
  • Bid / Ask-- / --
  • YTD % change+0.74%
  • Volume2,317,131
  • Average volume (10-day)1,782,589
  • Average volume (1-month)2,394,114
  • Average volume (3-month)2,353,317
  • 52-week range(U.S.) $81.12 to (U.S.) $121.75
  • Beta0.61
  • Trailing P/E36.11×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.61
Updated March 28 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue768739759697
Total other revenue--------
Total revenue768739759697
Gross profit555538557517
Total cost of revenue213201203180
Total operating expense567554590514
Selling / general / administrative234230229213
Research & development115113113102
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)574412
Other operating expenses, total1395
Operating income200185169183
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax200185169183
Income after tax159141127143
Income tax, total42444240
Net income159141127143
Total adjustments to net income--------
Net income before extra. items159141127143
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items159141127143
Inc. avail. to common incl. extra. items159141127143
Diluted net income159141127143
Dilution adjustment--0--0
Diluted weighted average shares218218217218
Diluted EPS excluding extraordinary itemsvalue per share0.730.650.580.66
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.740.670.730.70